Annual Cash & Cash Equivalents
$278.60 M
-$47.84 M-14.66%
December 31, 2023
Summary
- As of February 7, 2025, ADCT annual cash & cash equivalents is $278.60 million, with the most recent change of -$47.84 million (-14.66%) on December 31, 2023.
- During the last 3 years, ADCT annual cash & cash equivalents has fallen by -$160.60 million (-36.57%).
- ADCT annual cash & cash equivalents is now -40.28% below its all-time high of $466.54 million, reached on December 31, 2021.
Performance
ADCT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$274.27 M
-$25.85 M-8.61%
September 30, 2024
Summary
- As of February 7, 2025, ADCT quarterly cash and cash equivalents is $274.27 million, with the most recent change of -$25.85 million (-8.61%) on September 30, 2024.
- Over the past year, ADCT quarterly cash and cash equivalents has dropped by -$4.33 million (-1.55%).
- ADCT quarterly cash and cash equivalents is now -48.27% below its all-time high of $530.19 million, reached on September 30, 2021.
Performance
ADCT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ADCT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.7% | -1.6% |
| 3 y3 years | -36.6% | -41.2% |
| 5 y5 years | +100.7% | -41.2% |
ADCT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.3% | at low | -41.2% | +17.1% |
| 5 y | 5-year | -40.3% | +141.1% | -48.3% | +137.4% |
| alltime | all time | -40.3% | +141.1% | -48.3% | +137.4% |
ADC Therapeutics SA Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $274.27 M(-8.6%) |
| Jun 2024 | - | $300.12 M(+28.1%) |
| Mar 2024 | - | $234.28 M(-15.9%) |
| Dec 2023 | $278.60 M(-14.7%) | $278.60 M(-10.2%) |
| Sep 2023 | - | $310.41 M(-10.7%) |
| Jun 2023 | - | $347.51 M(+11.9%) |
| Mar 2023 | - | $310.55 M(-4.9%) |
| Dec 2022 | $326.44 M(-30.0%) | $326.44 M(-14.3%) |
| Sep 2022 | - | $380.86 M(+1.1%) |
| Jun 2022 | - | $376.78 M(-12.6%) |
| Mar 2022 | - | $430.87 M(-7.6%) |
| Dec 2021 | $466.54 M | $466.54 M(-12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $530.19 M(+42.6%) |
| Jun 2021 | - | $371.88 M(-2.9%) |
| Mar 2021 | - | $383.12 M(-12.8%) |
| Dec 2020 | $439.19 M(+280.1%) | $439.19 M(-11.2%) |
| Sep 2020 | - | $494.42 M(+41.8%) |
| Jun 2020 | - | $348.59 M(+201.7%) |
| Dec 2019 | $115.55 M(-16.8%) | - |
| Dec 2019 | - | $115.55 M(-36.6%) |
| Jun 2019 | - | $182.16 M(+31.2%) |
| Dec 2018 | $138.81 M(-47.2%) | - |
| Dec 2018 | - | $138.81 M |
| Dec 2017 | $262.75 M(+82.9%) | - |
| Dec 2016 | $143.67 M | - |
FAQ
- What is ADC Therapeutics SA annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual cash & cash equivalents year-on-year change?
- What is ADC Therapeutics SA quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly cash and cash equivalents year-on-year change?
What is ADC Therapeutics SA annual cash & cash equivalents?
The current annual cash & cash equivalents of ADCT is $278.60 M
What is the all time high annual cash & cash equivalents for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual cash & cash equivalents is $466.54 M
What is ADC Therapeutics SA annual cash & cash equivalents year-on-year change?
Over the past year, ADCT annual cash & cash equivalents has changed by -$47.84 M (-14.66%)
What is ADC Therapeutics SA quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ADCT is $274.27 M
What is the all time high quarterly cash and cash equivalents for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly cash and cash equivalents is $530.19 M
What is ADC Therapeutics SA quarterly cash and cash equivalents year-on-year change?
Over the past year, ADCT quarterly cash and cash equivalents has changed by -$4.33 M (-1.55%)